Home/Filings/4/0001437749-19-000994
4//SEC Filing

Wiseman John W. 4

Accession 0001437749-19-000994

CIK 0001013237other

Filed

Jan 16, 7:00 PM ET

Accepted

Jan 17, 5:16 PM ET

Size

34.9 KB

Accession

0001437749-19-000994

Insider Transaction Report

Form 4
Period: 2019-01-15
Wiseman John W.
EVP, Global Head of Sales
Transactions
  • Exercise/Conversion

    Common Stock

    2019-01-15$152.28/sh+1,827$278,2166,551 total
  • Exercise/Conversion

    Common Stock

    2019-01-15$160.58/sh+3,608$579,37310,959 total
  • Exercise/Conversion

    Common Stock

    2019-01-15$92.22/sh+612$56,4392,662 total
  • Exercise/Conversion

    Common Stock

    2019-01-15$94.84/sh+72$6,8282,734 total
  • Exercise/Conversion

    Common Stock

    2019-01-15$131.31/sh+1,990$261,3074,724 total
  • Sale

    Common Stock

    2019-01-15$205.56/sh6,094$1,252,6834,865 total
  • Sale

    Common Stock

    2019-01-15$205.02/sh240$49,2051,600 total
  • Sale

    Common Stock

    2019-01-15$205.39/sh310$63,6711,290 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-01-152100 total
    Exercise: $92.22Exp: 2022-11-01Common Stock (210 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-01-156120 total
    Exercise: $92.22Exp: 2022-11-01Common Stock (612 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-01-15720 total
    Exercise: $94.84Exp: 2021-11-01Common Stock (72 underlying)
  • Exercise/Conversion

    Common Stock

    2019-01-15$92.22/sh+210$19,3662,050 total
  • Exercise/Conversion

    Common Stock

    2019-01-15$159.14/sh+800$127,3127,351 total
  • Sale

    Common Stock

    2019-01-15$206.23/sh3,025$623,8461,840 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-01-151,9901,328 total
    Exercise: $131.31Exp: 2024-11-03Common Stock (1,990 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-01-151,8272,737 total
    Exercise: $152.28Exp: 2026-11-01Common Stock (1,827 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-01-15800534 total
    Exercise: $159.14Exp: 2025-05-01Common Stock (800 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-01-153,60814,425 total
    Exercise: $160.58Exp: 2027-07-06Common Stock (3,608 underlying)
Footnotes (10)
  • [F1]Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 6,094, the per share sales prices ranged from $205.10 to $206.09. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4.
  • [F10]Options granted on July 6, 2017 vest 20% annually on the anniversary date of the grant and are fully vested after five years.
  • [F2]Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 3,025, the per share sales prices ranged from $206.10 to $206.48. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4.
  • [F3]Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 310, the per share sales prices ranged from $205.38 to $205.51. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4.
  • [F4]Options granted on November 1, 2012 vest over a 5 year period with 40% exercisable two years after the grant date and the remainder vesting at a rate of 1.67% per month thereafter.
  • [F5]Options granted on November 1, 2012 vest over a 5 year period with 20% exercisable one year after the grant date and the remainder vesting at a rate of 1.67% per month thereafter.
  • [F6]Options granted on November 1, 2011 vest over a 5 year period with 20% exercisable one year after the grant date and the remainder vesting at a rate of 1.67% per month thereafter.
  • [F7]Options granted on November 3, 2014 vest over a 5 year period with 60% exercisable three years after the grant date and the remaining 40% vesting five years after the grant date.
  • [F8]Options granted on November 1, 2016 vest 20% annually on the anniversary date of the grant and are fully vested after five years.
  • [F9]Options granted on May 1, 2015 vest over a 5 year period with 60% exercisable three years after the grant date and the remaining 40% vesting five years after the grant date.

Issuer

FACTSET RESEARCH SYSTEMS INC

CIK 0001013237

Entity typeother

Related Parties

1
  • filerCIK 0001706225

Filing Metadata

Form type
4
Filed
Jan 16, 7:00 PM ET
Accepted
Jan 17, 5:16 PM ET
Size
34.9 KB